Skip to main content
. 2015 Dec 3;5:17742. doi: 10.1038/srep17742

Figure 3. Detection of infection in preclinical blood samples.

Figure 3

DDA signals from pooled blood samples taken at 20, 40, 60, 80, 100, 120, 140 dpi and clinical end-point (EP) from CD-1 mice infected with RML prions. Samples were analysed in triplicate in each of four independent assay runs. Data are shown as the mean chemiluminescent signal ratio relative to a cut-off (error bars indicating SEM) determined from the mean + 3× SD of control non-infected blood samples.